Approval of Libervant marks the first orally administered rescue medication for this age group to be cleared by the FDA for epilepsy.
FDA Approves Aquestive Therapeutics’ Libervant for the Treatment of Seizure Clusters in Children Aged 2 to 5 Years
Approval of Libervant marks the first orally administered rescue medication for this age group to be cleared by the FDA for epilepsy.